IP Library Granted Patent US 8,728,070
Granted Patent B2
US 8,728,070 · App. 14/061,638 · Granted May 20, 2014

Hepatic neuromodulation methods

Inventors: Bobak Robert Azamian (Newport Coast, CA); Scott Bradley Vafai (Boston, MA); Jonathan Allen Coe (Menlo Park, CA)
Assignee: Metavention, Inc.
A61B18/18A61B18/1492A61B17/00234A61B2018/00404A61B2018/00529A61B2018/00577A61B2017/00318
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,728,070
App. No.
14/061,638
Granted
May 20, 2014
Kind
B2
Abstract

According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.

Claims (40)

1. A method of facilitating thermally-induced hepatic neuromodulation in a subject, comprising:

inserting a radiofrequency (RF) catheter into a vasculature of a subject;

advancing the RF catheter to a location within a common hepatic artery of the vasculature; and

using the RF catheter to deliver RF energy to a wall of the common hepatic artery to neuromodulate one or more sympathetic nerves of a hepatic plexus to decrease a blood glucose level in the subject,

wherein the RF catheter comprises at least one electrode, and

wherein the at least one electrode is configured to contact the wall of the common hepatic artery while the RF energy is being delivered.

2. The method of claim 1 , wherein the at least one electrode is configured to maintain contact with the wall at a contact pressure of between 0.1 g/mm 2 and 10 g/mm 2 .

3. The method of claim 1 , wherein the neuromodulation is further effective to reduce at least one of a hepatic norepinephrine or a lipid level in the subject.

4. The method of claim 1 , wherein the RF catheter comprises a balloon catheter or a steerable distal tip.

5. The method of claim 1 , wherein the RF catheter is delivered over a guide wire.

6. The method of claim 1 , wherein the RF energy delivered by the at least one electrode is in the range of between 100 J and 1 kJ.

7. The method of claim 1 ,

wherein the RF energy is delivered at a frequency in the range of 50 kHz to 5 MHz; and

wherein the RF energy is delivered to heat the one or more sympathetic nerves to a temperature of up to 90 degrees Celsius and sufficient to cause ablation of the one or more sympathetic nerves.

8. The method of claim 1 , wherein the RF energy is delivered in a radial pattern to denervate the one or more sympathetic nerves at multiple locations without repositioning the RF catheter.

9. The method of claim 1 , further comprising providing cooling to a portion of a tissue that is not being targeted by the RF energy.

10. A method of facilitating thermally-induced hepatic neuromodulation in a subject, comprising:

delivering a radiofrequency (RF) catheter to a target region within a hepatic artery branch, the RF catheter comprising at least one electrode;

positioning the at least one electrode in contact with an inner wall of the hepatic artery branch; and

disrupting neural communication of one or more sympathetic nerves in the target region by applying an electrical signal to the at least one electrode, thereby causing conversion of electrical energy to thermal energy in the inner wall of the hepatic artery branch.

11. The method of claim 10 , wherein the hepatic artery branch is the common hepatic artery.

12. The method of claim 10 , wherein the hepatic artery branch is the proper hepatic artery.

13. The method of claim 10 , wherein the step of disrupting neural communication comprises permanently disabling neural communication of the one or more sympathetic nerves.

14. The method of claim 10 , wherein the step of disrupting neural communication comprises temporarily inhibiting or reducing neural communication of the one or more sympathetic nerves.

15. The method of claim 10 , wherein the RF catheter is delivered intravascularly.

16. The method of claim 10 ,

wherein the target region is the hepatic plexus,

wherein the RF energy is delivered to the hepatic plexus at a frequency in the range of 50 kHz to 5 MHz, and

wherein the RF energy is delivered to heat the one or more sympathetic nerves in the hepatic plexus to a temperature of up to 90 degrees Celsius and sufficient to cause ablation of the one or more sympathetic nerves.

17. A method of facilitating thermally-induced hepatic neuromodulation, comprising:

providing a neuromodulation system comprising a neuromodulation catheter configured for:

accessing a branch of a hepatic artery of a subject; and

delivering energy through a wall of the hepatic artery to the hepatic plexus,

wherein the delivered energy is sufficient to modulate one or more nerves within the hepatic plexus to affect at least one of a blood glucose level or a lipid level in the subject.

18. The method of claim 17 , wherein the delivered energy is sufficient to ablate the one or more nerves of the hepatic plexus.

19. The method of claim 17 , wherein the delivered energy is radiofrequency energy having a frequency in the range of 50 kHz to 5 MHz.

20. The method of claim 17 ,

wherein the delivered energy is delivered at a frequency in the range of 20 kHz to 20 MHz,

wherein the delivered energy heats the one or more nerves to a temperature of up to 90 degrees Celsius and sufficient to cause modulation of the one or more nerves; and

wherein the one or more nerves are sympathetic nerves.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2023
From: METAVENTION, INC.
To: MEDTRONIC IRELAND MANUFACTURING UNLIMITED COMPANY
Reel/Frame 064987/0161 →
RELEASE OF SECURITY INTEREST Recorded Aug 22, 2023
From: CUSTOMERS BANK (SUCCESSOR IN INTEREST TO SIGNATURE BANK)
To: METAVENTION, INC.
Reel/Frame 064670/0039 →
SECURITY INTEREST Recorded Jan 11, 2023
From: METAVENTION, INC.
To: RVLHC II, LLC, AS COLLATERAL AGENT
Reel/Frame 062349/0859 →
SECURITY INTEREST Recorded Oct 31, 2022
From: METAVENTION, INC.
To: RVLHC II, LLC, AS COLLATERAL AGENT
Reel/Frame 061602/0249 →
SECURITY INTEREST Recorded Jun 29, 2022
From: METAVENTION, INC.
To: RVLHC II, LLC, AS COLLATERAL AGENT
Reel/Frame 060358/0417 →
SECURITY INTEREST Recorded Dec 20, 2021
From: METAVENTION, INC.
To: SIGNATURE BANK
Reel/Frame 058433/0587 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2013
From: AZAMIAN, BOBAK ROBERT; COE, JONATHAN ALLEN; VAFAI, SCOTT BRADLEY
To: METAVENTION, INC.
Reel/Frame 031578/0683 →
Continuity (4)
Continuation 13789521 · Mar 7, 2013
Continuation PCTUS2012068630 · Dec 7, 2012
Provisional Application 61568843 · Dec 9, 2011
Related Publication 20140052122A1 · Feb 20, 2014